Primary Job Title Operating Partner Primary Organization Ampersand Capital Partners
Location New York, New York, United States Regions Greater New York Area, East Coast, Northeastern US Gender Male
Investor Type Investment Partner
Frank Witney brings more than 30 years of leadership and innovation in the research, development, and commercialization of many life science products, including diagnostic and analytical instruments to Affymetrix. He previously served at Affymetrix as Executive Vice President and Chief Commercial Officer following the acquisition of Panomics Inc.,
a quantitative biology company which Witney had pioneered and served as president and chief executive officer for six years.
Prior to returning to Affymetrix, Witney was President and Chief Executive Officer of Dionex Corporation, an ion and high performance liquid chromatography company which he led to an increase in market share across multiple markets and ultimately a successful acquisition by Thermo Fisher Scientific, Inc.
Witney also served as President and Chief Operating Officer of Packard BioScience, where he oversaw global operations, research and development, manufacturing, and worldwide sales, achieving rapid growth in revenues and operating profits. When Packard was acquired by PerkinElmer Life Sciences, he became President of PerkinElmer’s Drug Discovery Tools division, managing the reagent and instrument business units for high-throughput screening, research products, genomics/proteomics, and liquid handling automation.
Earlier in his management career, Witney held numerous positions at Bio-Rad Laboratories, including Group Operations Manager of the Life Science Group where he led successful efforts to enter rapidly growing markets for proteomics and bioassay technologies.
Witney was a post-doctoral fellow at the National Institutes of Health and holds a doctorate in molecular and cell biology from Indiana University.
